Markham, Canada
MedReleaf, a wholly owned subsidiary of Aurora Cannabis, is a prominent name in the Canadian medical cannabis sector. Established in 2013, the company has swiftly positioned itself as a leader through its focus on Research and Development and commitment to setting the medical grade standards. With operations rooted in Canada, MedReleaf operates two state-of-the-art facilities in Ontario, distinguished by their ICH-GMP and ISO 9001 certifications, ensuring top-notch cultivation processes.
Marking its latest financial milestone, MedReleaf secured a $152.38M Post-IPO Equity investment on 01 January 2018. As a powerhouse in the Health Care and Pharmaceutical industries, the company is a significant player in the global medical cannabis market, strategically expanding its footprint. With an unwavering dedication to innovation and operational excellence, MedReleaf continues to cultivate a diverse range of high-quality cannabis products for medical use worldwide.
